首页> 外国专利> Xanthine derivatives as A2B adenosine receptor antagonists suitable for treating conditions such as asthma and diarrhoea

Xanthine derivatives as A2B adenosine receptor antagonists suitable for treating conditions such as asthma and diarrhoea

机译:黄嘌呤衍生物作为A2B腺苷受体拮抗剂,适用于治疗哮喘和腹泻等疾病

摘要

Disclosed are compounds of formulae I and II, wherein X is optionally substituted arylene and the other substituents are as defined in the specification. The compounds are A2B adenosine receptor antagonists suitable for treating conditions such as atherosclerosis, angiogenesis, type II diabetes, diabetic retinopathy, cancer, asthma, inflammatory gastrointestinal tract disorders including diarrhea, and neurological disorders including senile dementia, Alzheimer's disease and Parkinson's disease. (62) Divided Out of 543416
机译:公开了式I和II的化合物,其中X是任选取代的亚芳基,并且其他取代基如说明书中所定义。该化合物是适用于治疗诸如动脉粥样硬化,血管生成,II型糖尿病,糖尿病性视网膜病,癌症,哮喘,炎性胃肠道疾病(包括腹泻)和神经系统疾病(包括老年性痴呆,阿尔茨海默氏病和帕金森氏病)的疾病的A2B腺苷受体拮抗剂。 (62)除以543416

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号